Alkermes (ALKS) Times Interest Earned (2010 - 2026)
Alkermes' (ALKS) quarterly Times Interest Earned came in at -$0.42 in Q1 2026, down 107.57% year-on-year from $5.52 in Q1 2025, and down 108.82% on a QoQ basis from $4.73 in Q4 2025.
Alkermes (ALKS) Times Interest Earned (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has 17 years of Times Interest Earned data on file, last reported at -$0.42 in Q1 2026.
- On a quarterly basis, Times Interest Earned fell 107.57% year-over-year to -$0.42 in Q1 2026; TTM through Mar 2026 was $1.66, a 90.68% decrease from a year earlier, with the FY2025 full-year figure at $3.05, down 28.14% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$0.42, down from $4.73 in the prior quarter.
- Over the last five years, Times Interest Earned for ALKS reached as high as $709.17 in Q4 2022 and fell as low as -$13.48 in Q3 2022.
- Historically, Times Interest Earned has averaged $48.82 across 5 years, with a median of $5.52 in 2025.
- On a YoY basis, Times Interest Earned climbed as much as 3166.46% in 2022 and fell as far as 862.07% in 2022.
- Year by year, Times Interest Earned stood at $709.17 in 2022, then plunged by 98.73% to $9.02 in 2023, then surged by 140.38% to $21.69 in 2024, then tumbled by 78.18% to $4.73 in 2025, then tumbled by 108.82% to -$0.42 in 2026.
- Per Business Quant data, the three most recent Times Interest Earned figures were -$0.42 in Q1 2026, $4.73 in Q4 2025, and $0.96 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 0.18 |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 5.11 |
| 10 | Alkermes | 8.78 Bn | 8.27 Bn | 331.33 Mn | -0.42 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.42 |
| Dec 31, 2025 | 4.73 |
| Sep 30, 2025 | 0.96 |
| Jun 30, 2025 | 0.99 |
| Mar 31, 2025 | 5.52 |
| Dec 31, 2024 | 21.69 |
| Sep 30, 2024 | 17.46 |
| Jun 30, 2024 | 18.46 |
| Mar 31, 2024 | 7.24 |
| Dec 31, 2023 | 9.02 |
| Sep 30, 2023 | 14.85 |
| Jun 30, 2023 | 49.48 |
| Mar 31, 2023 | -2.07 |
| Dec 31, 2022 | 709.17 |
| Sep 30, 2022 | -13.48 |
| Jun 30, 2022 | -7.66 |
| Mar 31, 2022 | -6.04 |
| Dec 31, 2021 | -23.13 |
| Sep 30, 2021 | -4.47 |
| Jun 30, 2021 | 1.00 |